India orders top drugmaker to halt eye medicine production at plant over quality lapses

Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.channelnewsasia.com)